Hypertension and incident cardiovascular events after next-generation BTKi therapy initiation
2022 · Journal of Hematology & Oncology · 34 citations
https://doi.org/10.1186/s13045-022-01302-7
M
Marilly Palettas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
114
Papers
1.1K
Citations
18
h-index
30
i10-index
Marilly Palettas is an academic researcher from The Ohio State University Wexner Medical Center. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Treatment and Pharmacology & Chronic Lymphocytic Leukemia Research. The author has an h-index of 18, co-authored 97 publications.
ORCID: 0000-0002-6256-320XPapers by this author
worksClinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer
2020 · Cardio-Oncology · 31 citations
https://doi.org/10.1186/s40959-020-00081-9
HTLV-1 CTCF-binding site is dispensable for in vitro immortalization and persistent infection in vivo
2019 · Retrovirology · 23 citations
https://doi.org/10.1186/s12977-019-0507-9
Trends in Acute Pain Management for Renal Colic in the Emergency Department at a Tertiary Care Academic Medical Center
2020 · Journal of Endourology · 18 citations
https://doi.org/10.1089/end.2020.0402
Quality of Life and Real-time Patient Experience During Neoadjuvant Therapy
2023 · Annals of Surgery · 8 citations
https://doi.org/10.1097/sla.0000000000006090
Impact of Dose Intensity on Pathologic Complete Response Rate in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab and Pertuzumab (TCHP)
2022 · Targeted Oncology · 4 citations
https://doi.org/10.1007/s11523-022-00874-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat